14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 CRBP stock ended at $38.77. This is 1.49% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.87% from a day low at $37.41 to a day high of $39.23.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Corbus Pharmaceuticals Holdings prices

Date Open High Low Close Volume
Feb 22, 2023 $2.85 $2.91 $2.76 $2.79 61 375
Feb 21, 2023 $3.06 $3.06 $2.77 $2.77 132 351
Feb 17, 2023 $3.20 $3.23 $3.00 $3.06 183 304
Feb 16, 2023 $3.08 $3.47 $3.01 $3.20 190 956
Feb 15, 2023 $3.32 $3.55 $3.01 $3.08 214 412
Feb 14, 2023 $3.72 $4.02 $3.11 $3.28 373 112
Feb 13, 2023 $4.94 $4.99 $3.90 $4.27 79 880
Feb 10, 2023 $5.06 $5.10 $4.63 $4.80 30 636
Feb 09, 2023 $5.17 $5.17 $4.86 $5.03 21 865
Feb 08, 2023 $5.07 $5.19 $4.86 $5.16 24 507
Feb 07, 2023 $5.18 $5.31 $4.50 $4.93 83 157
Feb 06, 2023 $5.67 $5.67 $5.16 $5.18 42 883
Feb 03, 2023 $5.25 $5.64 $5.14 $5.15 65 019
Feb 02, 2023 $5.10 $5.67 $5.10 $5.24 225 942
Feb 01, 2023 $4.80 $4.95 $4.67 $4.92 50 038
Jan 31, 2023 $4.55 $4.80 $4.50 $4.65 47 632
Jan 30, 2023 $4.41 $4.50 $4.21 $4.50 33 603
Jan 27, 2023 $4.20 $4.50 $4.15 $4.34 45 384
Jan 26, 2023 $4.41 $4.41 $4.11 $4.20 30 189
Jan 25, 2023 $4.41 $4.46 $4.06 $4.13 24 902
Jan 24, 2023 $4.23 $4.28 $4.08 $4.20 27 591
Jan 23, 2023 $4.35 $4.35 $4.05 $4.20 34 931
Jan 20, 2023 $4.20 $4.35 $4.05 $4.20 30 922
Jan 19, 2023 $4.15 $4.34 $3.99 $4.20 33 859
Jan 18, 2023 $4.50 $4.50 $4.05 $4.14 47 890
Click to get the best stock tips daily for free!

About Corbus Pharmaceuticals Holdings

Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the act... CRBP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT